DUBLIN--(BUSINESS WIRE)--The "North America Needle-free Injection Systems Market Analysis (2017-2023)" report has been added to ResearchAndMarkets.com's offering.
The North America Needle-free Injection Systems Market would witness market growth of 16% CAGR during the forecast period (2017 - 2023).
Needle free injection technology (NFIT) includes a wide range of drug delivery systems which are used to drive drugs through the skin using any of the forces such as Lorentz, Shock waves, pressure by gas or electrophoresis. The process propels the drug to pass through the skin, and virtually nullifies the use of hypodermic needles.
North America is the region with tremendous market opportunities. The demand for self-administration and rising prevalence of chronic diseases and conditions such as heart disease, stroke, cancer, type 2 diabetes, obesity, and arthritis are the factors driving market growth in North America.
Key Topics Covered:
1. Market Scope & Methodology
2. Market Overview
3. North America Needle-free Injection Systems Market
4. North America Needle-free Injection Systems Market by Source of Power
5. North America Needle-free Injection Systems Market by Type
6. North America Needle-free Injection Systems Market by Site of Delivery
7. North America Needle-free Injection Systems Market by Usability
8. North America Needle-free Injection Systems Market by Application
9. North America Needle-free Injection Systems Market by Country
10. Company Profiles
- Endo International PLC
- Antares Pharma, Inc.
- Pharmajet
- Medical International Technology, Inc. (MIT)
- Injex Pharma AG
- Valeritas, Inc.
- European Pharma Group BV
- Portal Instruments
-
Bioject Medical Technologies Inc.
For more information about this report visit https://www.researchandmarkets.com/research/bxst8d/north_america?w=4
